By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines.

Contact Information

Website: www.evolus.com
Email: IR@Evolus.com
Main Phone: +1 949 284-4555
Address: 520 Newport Center Drive
Address 2: Suite 1200
State: CA
City / Town: Newport Beach
Country: US
Postal Code: 92660

Issuer Information

Exchange: NSD
CEO: David Moatazedi
Employees: 119
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A